Hans K Hasselbalch
Clinical Professor
Department of Clinical Medicine
Køgevej 7 - 13, 4000 Roskilde
Member of:
Internal Medicine: Haematology
1 - 3 out of 3Page size: 10
- 2013
- Published
The role of cytokines in the initiation and progression of myelofibrosis
Hasselbalch, Hans Carl, Apr 2013, In: Cytokine & Growth Factor Reviews. 24, 2, p. 133-45 13 p.Research output: Contribution to journal › Journal article › peer-review
- Published
Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
Hasselbalch, Hans Carl, Feb 2013, In: Leukemia Research. 37, 2, p. 214-20 7 p.Research output: Contribution to journal › Journal article › peer-review
- Published
Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
Silver, R. T., Kiladjian, J. & Hasselbalch, Hans Carl, Feb 2013, In: Expert Review of Hematology. 6, 1, p. 49-58 10 p.Research output: Contribution to journal › Journal article › peer-review
ID: 2849472
Most downloads
-
159
downloads
A nationwide population-based cross-sectional survey of health-related quality of life in patients with myeloproliferative neoplasms in Denmark (MPNhealthSurvey): survey design and characteristics of respondents and nonrespondents
Research output: Contribution to journal › Journal article › peer-review
Published -
150
downloads
Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations
Research output: Contribution to journal › Journal article › peer-review
Published -
135
downloads
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
Research output: Contribution to journal › Journal article › peer-review
Published